Anti-PD-1 Blockade with Nivolumab with and without Therapeutic Vaccination for Virally Suppressed Chronic Hepatitis B: A Pilot Study.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2019.06.028
Abstract: BACKGROUND AND AIMS To evaluate the hypothesis that increasing T-cell frequency and activity may provide durable control of hepatitis B virus (HBV), we administered nivolumab, a PD-1 inhibitor, with or without GS-4774, an HBV therapeutic… read more here.
Keywords: anti blockade; week; hepatitis; nivolumab without ... See more keywords
One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac291
Abstract: Abstract Background We determined the frequency of and factors associated with ≥10% weight gain and its metabolic effects in virally suppressed people with human immunodeficiency virus (PWH) from the Dutch national AIDS Therapy Evaluation in… read more here.
Keywords: virally suppressed; taf insti; gain; weight gain ... See more keywords
Longitudinal HIV care outcomes by gender identity in the United States
Sign Up to like & getrecommendations! Published in 2022 at "AIDS"
DOI: 10.1097/qad.0000000000003339
Abstract: Objective: Describe engagement in HIV care over time after initial engagement in HIV care, by gender identity. Design: Observational, clinical cohort study of people with HIV engaged in routine HIV care across the United States.… read more here.
Keywords: hiv care; virally suppressed; care; gender identity ... See more keywords
Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV.
Sign Up to like & getrecommendations! Published in 2023 at "AIDS"
DOI: 10.1097/qad.0000000000003572
Abstract: OBJECTIVE Neuroimmune activation is a putative driver of cognitive impairment in people with HIV (PWH), even in the age of modern antiretroviral therapy. Nevertheless, imaging of the microglial marker, the 18kDa translocator protein (TSPO), with… read more here.
Keywords: factor receptor; stimulating factor; 11c cppc; virally suppressed ... See more keywords
Children and adolescents on anti-retroviral therapy in Bulawayo, Zimbabwe: How many are virally suppressed by month six?
Sign Up to like & getrecommendations! Published in 2020 at "F1000Research"
DOI: 10.12688/f1000research.22744.1
Abstract: Background: Zimbabwe is one of the countries in sub-Saharan Africa disproportionately affected by human immunodeficiency virus. In the “treat all” era, we assessed the gaps in routine viral load (VL) monitoring at six months for… read more here.
Keywords: six months; retroviral therapy; children adolescents; virally suppressed ... See more keywords
Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate
Sign Up to like & getrecommendations! Published in 2021 at "Southern African Journal of HIV Medicine"
DOI: 10.4102/sajhivmed.v22i1.1243
Abstract: Background Tenofovir disoproxil fumarate (TDF) is included in first-line antiretroviral treatment (ART) for adolescents living with HIV (ALWH). Associated toxicities remain a concern. Objective We evaluated bone and renal safety outcomes in virologically suppressed South… read more here.
Keywords: tenofovir disoproxil; disoproxil fumarate; virally suppressed; hiv ... See more keywords